These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8768044)

  • 1. [Lymph node diagnosis with imaging methods. An overview with special reference to recent developments in the area of MR contrast media].
    Mohr U; Weissleder R
    Z Lymphol; 1996 Jun; 20(1):15-20. PubMed ID: 8768044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The magnetic resonance tomographic differential diagnosis between reactively enlarged lymph nodes and cervical lymph node metastases].
    Steinkamp HJ; Heim T; Schubeus P; Schörner W; Felix R
    Rofo; 1992 Oct; 157(4):406-13. PubMed ID: 1391845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Lymph node staging in cervix carcinomas: the results of high-resolution magnetic resonance tomography (MRT) with a phased-array body coil].
    Heuck A; Scheidler J; Kimmig R; Müller-Lisse U; Steinborn M; Helmberger T; Reiser M
    Rofo; 1997 Mar; 166(3):210-4. PubMed ID: 9156591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macromolecular intravenous contrast agent for MR lymphography: characterization and efficacy studies.
    Harika L; Weissleder R; Poss K; Papisov MI
    Radiology; 1996 Feb; 198(2):365-70. PubMed ID: 8596833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical utility of Gd-DTPA-enhanced magnetic resonance imaging in lung cancer.
    Kono M; Adachi S; Kusumoto M; Sakai E
    J Thorac Imaging; 1993; 8(1):18-26. PubMed ID: 8418316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical use of contrast media in magnetic resonance imaging.
    Bydder GM
    Br J Hosp Med; 1990 Feb; 43(2):149-52. PubMed ID: 2178714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [MR imaging of lymph nodes using Gadofluorine M: feasibility in a swine model at 1.5 and 3T].
    Spuentrup E; Ruhl K; Weigl S; Misselwitz B; Wardeh D; Buhl A; Botnar RM; Katoh M; Wiethoff AJ; Günther RW
    Rofo; 2010 Aug; 182(8):698-705. PubMed ID: 20419610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noninvasive detection of clinically occult lymph-node metastases in prostate cancer.
    Harisinghani MG; Barentsz J; Hahn PF; Deserno WM; Tabatabaei S; van de Kaa CH; de la Rosette J; Weissleder R
    N Engl J Med; 2003 Jun; 348(25):2491-9. PubMed ID: 12815134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MR lymphography with a lymphotropic T1-type MR contrast agent: Gd-DTPA-PGM.
    Harika L; Weissleder R; Poss K; Zimmer C; Papisov MI; Brady TJ
    Magn Reson Med; 1995 Jan; 33(1):88-92. PubMed ID: 7891541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical applications of contrast agents in body imaging.
    Bydder GM
    Top Magn Reson Imaging; 1991 Mar; 3(2):74-84. PubMed ID: 2025434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of two different iron oxide-based contrast agents for discrimination of benign and malignant lymph nodes.
    Kinner S; Maderwald S; Albert J; Parohl N; Corot C; Robert P; Baba HA; Barkhausen J
    Invest Radiol; 2012 Sep; 47(9):511-5. PubMed ID: 22864375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic performance of nanoparticle-enhanced magnetic resonance imaging in the diagnosis of lymph node metastases in patients with endometrial and cervical cancer.
    Rockall AG; Sohaib SA; Harisinghani MG; Babar SA; Singh N; Jeyarajah AR; Oram DH; Jacobs IJ; Shepherd JH; Reznek RH
    J Clin Oncol; 2005 Apr; 23(12):2813-21. PubMed ID: 15837995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Gd [DTPA-bis (2-aminoethoxy) ethane] polymeric contrast agent with gadodiamide injection for interstitial MR lymphography: experimental study with rabbits.
    Zhou Z; Guo J; Yu H; Zhu B; Liu C; Jiang X; Zhang M; Chen J
    J Magn Reson Imaging; 2005 Sep; 22(3):361-7. PubMed ID: 16106365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Lymph node imaging with ultra-rapid 3D MR angiography].
    Georgi M; Gaa J; Teubner J; Bolte R
    Rofo; 1999 Feb; 170(2):218-21. PubMed ID: 10101366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Value of contrast-enhanced ultrasound vs. CT and MRI in palpable enlarged lymph nodes of the head and neck].
    Schröder RJ; Rost B; Hidajat N; Rademaker J; Felix R; Mäurer J
    Rofo; 2002 Sep; 174(9):1099-106. PubMed ID: 12221567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Studies on magnetic resonance imaging of pancreatic cancer].
    Hirose Y
    Nihon Geka Hokan; 1991 Sep; 60(5):316-26. PubMed ID: 1820003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional magnetic resonance imaging using iron oxide particles in characterizing head and neck adenopathy.
    Hoffman HT; Quets J; Toshiaki T; Funk GF; McCulloch TM; Graham SM; Robinson RA; Schuster ME; Yuh WT
    Laryngoscope; 2000 Sep; 110(9):1425-30. PubMed ID: 10983936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relaxometry of magnetic resonance imaging contrast agents.
    Koenig SH; Brown RD
    Magn Reson Annu; 1987; ():263-86. PubMed ID: 3079341
    [No Abstract]   [Full Text] [Related]  

  • 19. MR contrast agents in lymph node imaging.
    Misselwitz B
    Eur J Radiol; 2006 Jun; 58(3):375-82. PubMed ID: 16464554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidentally discovered adrenal masses.
    Francis IR; Korobkin M
    Magn Reson Imaging Clin N Am; 1997 Feb; 5(1):147-64. PubMed ID: 8995130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.